News and Press Releases
Novonesis expands global footprint with acquisition of production facility in Southeast Asia
Investment of around USD 50 million strengthens fermentation capabilities and supports the company’s long-term growth ambitions 8 April 2026 -- Copenhagen, Denmark -- Novonesis has signed an agreement with Meihua to...
Category: Manufacturing and Packing, Other, Pharmaceutical
Posted: April 8, 2026
BRAIN Biotech has been granted a key patent for its CRISPR-BMC genome-editing technology
Newly patented CRISPR nuclease exhibits high activity in various prokaryotic and eukaryotic organismsPatent now opens up significant potential for further commercial use through licensing BRAIN Biotech offers its technology for...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 23, 2026
Codexis signs agreement to manufacture 50g siRNA using its ECO Synthesis Manufacturing Platform
4 March 2026 -- California, US -- Codexis, Inc, a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced it has entered into an agreement with...
Category: BioManufacturing, Drug Discovery, Other, Pharmaceutical
Posted: March 4, 2026
BRAIN Biotech announces 3M 25/26 results and breakthrough at BioIncubator company SolasCure
Aurase Wound Gel showing strong clinical evidence of superior debridement and healing in chronic wounds Aurase shows dual action on chronic wound debridement and healing SolasCure preparing fund raising for...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: February 25, 2026
SolasCure completes phase II clinical trial, demonstrating accelerated healing with Aurase Wound Gel
Aurase Wound Gel shows 22x faster debridement and 7x faster healing compared to standard of care in sloughy venous leg ulcers, supporting advancement to the next phase of development Data...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: February 24, 2026
EuroPCR 2025: Late-Breaking Data Demonstrate Sustained Significantly Lower Event Rates With Elixir Medical’s DynamX Bioadaptor Over Drug-Eluting Stent Through Three Years
Sustained durability of treatment effect with significantly lower TLF rates (2.7% versus 7.2%, p=0.030) with DynamX compared to DES Significantly lower rate of Cardiac Death (0.5% versus 3.2%, p=0.033) with...
Category: Biotechnology, Clinical Trials, Other
Posted: May 21, 2025
Novo Nordisk A/S: Rybelsus® (oral semaglutide 14mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 2025
Rybelsus reduced major adverse cardiovascular events by 14% vs placebo in adults with type 2 diabetes and cardiovascular and/or chronic kidney disease in the SOUL cardiovascular outcomes trial Data were...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 29, 2025
Cleerly to Present Late-Breaking Clinical Trial Results on Cardiovascular Risk in Women at ACC 25
Cleerly to Present Late-Breaking Findings and Participate in Key ACC 25 Sessions 27 March 2025 -- Illinois, US -- Cleerly, the leader in cardiovascular AI imaging, announces its participation in...
Category: Clinical Trials, Other, Pharmaceutical
Posted: March 27, 2025
Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for Platinum-resistant Ovarian Cancer
24 March 2025 -- California, US and Suzhou, China -- Innovent Biologics, Inc, a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology,...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: March 24, 2025
Novonesis probiotic strain receives health claim in Canada
Health Canada authorizes functional claims that the new probiotic strain CLEPIUS™ “helps alleviate perceived stress and improve irritable bowel syndrome-related quality of life in adults” 11 March 2024 -- Copenhagen,...
Category: Biotechnology, Other, Pharmaceutical
Posted: March 11, 2025
Venus Remedies gets Marketing Authorization for anticoagulant ‘Enoxaparin’ from Indonesia
Latest approvals from Indonesia, Southeast Asia’s largest pharma market, to help strengthen company’s regional and global aspirations 10 February 2025 -- Panchkula, India -- Venus Remedies Limited, a leading Indian exporter...
Category: Drug Delivery, Other, Pharmaceutical
Posted: February 10, 2025
51-52, Industrial Area Phase-1, Panchkula, Haryana, 134113
Shockwave Medical to Participate in the 23rd Annual Needham Virtual Healthcare Conference
26 March 2024 -- California, US -- Shockwave Medical, a pioneer in the development and commercialisation of transformational technologies for the treatment of cardiovascular disease, announced today that the company...
Category: Biotechnology
Posted: March 26, 2024
Novo Nordisk to acquire Cardior Pharmaceuticals and strengthenpipeline in cardiovascular disease
25 March, 2024 -- Bagsværd, Denmark, and Hannover, Germany -- Novo Nordisk and CardiorPharmaceuticals today announced that Novo Nordisk has agreed to acquire Cardior for up to€1.025bn, including an upfront...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: March 26, 2024
